Abstract

Monocytic and granulocytic myeloid-derived suppressor cells together with tumor-infiltrating macrophages constitute the main tumor-infiltrating immunosuppressive myeloid populations. Due to the phenotypic resemblance to conventional myeloid cells, their identification and purification from within the tumors is technically difficult and makes their study a challenge. We differentiated myeloid cells modeling the three main tumor-infiltrating types together with uncommitted macrophages, using ex vivo differentiation methods resembling the tumor microenvironment. The phenotype and proteome of these cells was compared to identify linage-dependent relationships and cancer-specific interactome expression modules. The relationships between monocytic MDSCs and TAMs, monocytic MDSCs and granulocytic MDSCs, and hierarchical relationships of expression networks and transcription factors due to lineage and cancer polarization were mapped. Highly purified immunosuppressive myeloid cell populations that model tumor-infiltrating counterparts were systematically analyzed by quantitative proteomics. Full functional interactome maps have been generated to characterize at high resolution the relationships between the three main myeloid tumor-infiltrating cell types. Our data highlights the biological processes related to each cell type, and uncover novel shared and differential molecular targets. Moreover, the high numbers and fidelity of ex vivo-generated subsets to their natural tumor-shaped counterparts enable their use for validation of new treatments in high-throughput experiments.

Highlights

  • The tumor microenvironment (TME) is composed of cancer cells and other cell types which include tumor-infiltrating immune cells

  • To generate myeloid cell preparations modeling tumor-infiltrating subsets, we applied an ex vivo-differentiation system that mimics the conditions within the TME

  • We previously developed an ex vivo differentiation system of myeloid derived suppressor cells (MDSCs) that closely resemble tumor-infiltrating counterparts

Read more

Summary

Introduction

The tumor microenvironment (TME) is composed of cancer cells and other cell types which include tumor-infiltrating immune cells. MDSCs and TAMs exert strong T cell-inhibitory functions through cell-to-cell contacts and production of immunosuppressive cytokines [4,5,6]. In advanced cancers, their expansion contributes to broad systemic immunosuppression in patients [7]. Their expansion contributes to broad systemic immunosuppression in patients [7] In this way, TAMs and MDSCs overtake the control of anti-tumor immune responses in the patient. TAMs and MDSCs overtake the control of anti-tumor immune responses in the patient Their increase is a clinical marker of poor prognosis, and they constitute potential targets for improving anti-cancer therapies [8]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call